Rein Therapeutics Inc. ( RNTX) - Key Metrics
RNTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.10 | -$0.13 | -$0.13 |
| 2026Q1 | $0 | -$0.19 | -$0.11 | -$0.11 |
| 2025Q4 | $0 | -$1.26 | -$0.13 | -$0.13 |
| 2025Q3 | $0 | -$0.21 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.28 | -$0.27 | -$0.27 |
RNTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.60 |
| 2026Q1 | 0% | -1.71 |
| 2025Q4 | 0% | -0.24 |
| 2025Q3 | 0% | -1.37 |
| 2025Q2 | 0% | -1.25 |
RNTX
Price: $0.60
52 week price:
Earnings Per Share: -1.54 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.4 million